Insiders Updates Recent Insider Activity Could Benefit Gilead Sciences, Inc (GILD) Gilead Sciences, Inc’s filing revealed that its Chairman & CEO O’Day Daniel Patrick unloaded Company’s shares for reported $1.14 million
Analysts Viewpoint Analysts: GILD stock price target of 126 in 12 months Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Featured Watch These 4 Stocks on Friday Stocks closed slightly higher yesterday in their first winning session since the start of the week. The S&P 500 and